Le Lézard
Classified in: Health, Science and technology

Cantata Health Unveils Key Additions to EHR Software for Long-term Care Providers


AUSTIN, Texas, Dec. 13, 2018  Cantata Health, a leading provider of software and services that improves patient visibility, operational efficiency and financial outcomes, introduced new enhancements to its NetSolutionstm platform. The new features and partnerships allow LTC providers to focus on quality care and financial leadership, rather than technology and screen time.

Enhancements made to EHR and Financial Management modules on the NetSolutions Long-Term Care (LTC) Platform include:

"We continue to drive enhancements to NetSolutions that provide visibility to all aspects of the patient care continuum while ensuring the financial health of the facility," said Les Wilson, Sr. Director of Product Management for Cantata Health. "The new features and functionality will help facility administration and staff make more informed decisions on patient care and back-office operations."

To learn more about Cantata Health's solutions for Long-Term Care Facilities, visit: http://www.cantatahealth.com/solutions/net-solutions

About Cantata Health

Cantata Health delivers award-winning Revenue Cycle Management (RCM) and Electronic Health Records (EHR) software for acute, post-acute and long-term care (LTC) facilities purpose-built for the unique needs of each facility or system. Cantata's configurable solutions provide leaders greater visibility to patient care across the continuum of care and predictable financial outcomes: improving back-office operations, clinical efficiency, and revenue recovery. Headquartered in Austin, Texas, our team of experts provide uncommonly attentive service and support focused on improving key quality outcomes.

 

SOURCE Cantata Health


These press releases may also interest you

at 07:56
Medtronic plc , a global leader in healthcare technology, today announced that the U.S. Food and Drug Administration (FDA) has approved the Inceptivtm closed-loop rechargeable spinal cord stimulator (SCS) for the treatment of chronic pain. Inceptiv...

at 07:55
The "KEYTRUDA Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering. The report provides comprehensive insights about KEYTRUDA for ovarian cancer in the seven major markets. A detailed...

at 07:50
The "Peptide Synthesis Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Type of Peptide Synthesis Method, Type of Chemical Synthesis, Contract Manufacturing Organization Size, Key Geographical Regions" report has been added to...

at 07:45
The "Laboratory Filtration Equipment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Global Laboratory Filtration Equipment Market to Reach $3 Billion by 2030 The global market for Laboratory...

at 07:40
The "Global Weight Loss Drugs Market: Analysis By Product Type, By Drug Type, By Distribution Channel, By End User, By Region, Size and Trends with Impact of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's...

at 07:35
Arrowhead Pharmaceuticals, Inc. today announced its plan to host a 2024 Summer Series of R&D webinars that highlight multiple clinical stage RNA interference (RNAi) based medicines that utilize the company's proprietary Targeted RNAi Molecule...



News published on and distributed by: